Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

443
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
443
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

69
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
69
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

102
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
102
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

125
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
125
Bipolar Disorder01:30

Bipolar Disorder

41
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
41
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Ensifentrine: A Novel Option for Maintenance of Chronic Obstructive Pulmonary Disease.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2025
Same author

Ceftobiprole: A therapeutic update.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2025
Same author

Capivasertib.

Hospital pharmacy·2024
Same author

Zuranolone: A Narrative Review of a New Oral Treatment for Postpartum Depression.

Clinical therapeutics·2024
Same author

Rozanolixizumab: A New Therapy in the Treatment of Myasthenia Gravis.

The Annals of pharmacotherapy·2024

相关实验视频

Updated: May 25, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K

布雷克西普拉:风险与益处的平衡

Emily M Hitt1

  • 1Washington State University College of Pharmacy and Pharmaceutical Sciences, Spokane, Washington.

The Senior care pharmacist
|February 27, 2025
PubMed
概括
此摘要是机器生成的。

布雷克斯皮普拉是FDA批准的第一个用于阿尔茨海默病激发的药物. 临床研究表明,它是一种安全有效的治疗选择,用于管理痴呆症中这些具有挑战性的行为和心理症状.

更多相关视频

Self-Administration of Drugs in Mouse Models of Feeding and Obesity
03:37

Self-Administration of Drugs in Mouse Models of Feeding and Obesity

Published on: June 8, 2021

4.3K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.4K

相关实验视频

Last Updated: May 25, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K
Self-Administration of Drugs in Mouse Models of Feeding and Obesity
03:37

Self-Administration of Drugs in Mouse Models of Feeding and Obesity

Published on: June 8, 2021

4.3K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.4K

科学领域:

  • 神经科学是一个神经科学.
  • 老年病的医生 老年病的医生
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 阿尔茨海默病是痴呆的主要原因,常常伴随着痴呆症 (BPSD) 的行为和心理症状.
  • 管理BPSD是复杂的,有史以来有限的FDA批准的药理选择,导致非标签药物使用.
  • 兴奋是一种常见且具有影响力的BPSD,显著影响患者的预后和护理.

研究的目的:

  • 审查布雷克斯皮普拉的临床概况,重点关注其在老年患者中的安全性和有效性.
  • 检查支持FDA批准布雷克斯皮普拉用于阿尔茨海默病相关激动症的III期研究.
  • 评估布雷克斯皮普拉在BPSD治疗领域的潜在作用和影响.

主要方法:

  • 来自两项III期研究的临床试验数据的综述,评估了布雷克斯皮普拉对阿尔茨海默病痴呆症的激发作用.
  • 对目标患者群体的安全性,疗效和耐受性数据的分析.
  • 对布雷克斯皮普拉的药理性质的评估,包括它对各种单氨基受体的亲和力.

主要成果:

  • 两项III期研究表明,布雷克斯皮普拉是一种潜在的安全,有效和耐受性良好的治疗与阿尔茨海默氏症痴呆症相关的激动症.
  • 布雷克西普拉在减轻痴呆症老年人激动症状方面表现出有效性.
  • 该药物在该人群中的安全性和耐受性概况与更广泛的临床试验中发现的结果一致.

结论:

  • 布雷克西普拉是一种新的,FDA批准的治疗选择,用于管理阿尔茨海默氏症痴呆症的激发.
  • 虽然有效,但仔细的患者评估至关重要,以平衡布雷克斯皮普拉的益处与潜在风险.
  • 这种批准为临床医生管理复杂和多因素的BPSD提供了一个新的途径.